insights_auto
Why is AGIO down ၃.၁၀%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၈.၇၆ US$
arrow_downward
-၃.၁၀%(-၀.၉၂) 1D
၂၈.၇၆ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၁၉, GMT-၅ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၂၉.၉၃ US$
High
၃၀.၃၅ US$
Low
၂၈.၇၁ US$
Mkt. cap
၁၇၂.၀၁ ဋေ
Avg. vol.
၁.၁၈ သန်း
Volume
၅.၉၀ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၂၉.၉၃ US$
High
၃၀.၃၅ US$
Low
၂၈.၇၁ US$
Mkt. cap
၁၇၂.၀၁ ဋေ
Avg. vol.
၁.၁၈ သန်း
Volume
၅.၉၀ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
Stocktwits
·
ပြီးခဲ့သည့် ၂၈ မိနစ်
Why Are Nasdaq, Dow, S&P 500 Futures Trading Lower After Anthropic’s Debut?
FOREX.com
·
ပြီးခဲ့သည့် ၄ နာရီ
S&P 500 Analysis: SPX Is Going Through One of Its Most Difficult Periods of 2026
Traders Union
·
ပြီးခဲ့သည့် ၅ နာရီ
S&P 500 sees $2 trillion swing and 8.5 percent drop, Peter Tuchman notes
BigGo Finance
·
ပြီးခဲ့သည့် ၂ နာရီ
Chip ETF Eyes Unprecedented Fourth Straight Year of Beating the S&P 500
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc